glp 1 delayed gastric emptying Gastrointestinal effects of GLP-1 receptor agonists: mechanisms, management, and future directions GLP-1 Agonist-Induced Delayed Gastric Emptying

(Source 1) Iron deficiency exists on a spectrum from depleted iron stores to iron-deficiency anemia

Choi, M, Kadara H, Zhang J, Parra Cuentas E, Rodriguez Canales J, Gaffney SG, Zhao Z, Behrens C, Fujimoto J, Chow C, Kalhor N, Moran C, Rimm D, Swisher SG , Gibbons DL, Heymach JV, Kaftan E, Townsend J, Lynch TJ, Schlessinger J, Lee JJ, Lifton R, Herbst RS, Wistuba II

We're going for a much more delicate approach

Peptide medications, like most GLP-1 drugs, are especially challenging to deliver through the skins barrier because of their large molecular size

The patient interest comes mostly from athletes and recovery-focused patients

Tirzepatide is available in multiple dose strengths from 2.5 mg to 15 mg, allowing researchers to find their optimal balance between efficacy and side effects